These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19903829)

  • 1. A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints.
    Selent J; Bauer-Mehren A; López L; Loza MI; Sanz F; Pastor M
    Mol Pharmacol; 2010 Feb; 77(2):149-58. PubMed ID: 19903829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity metrics for ligands reflecting the similarity of the target proteins.
    Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
    J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.
    Jensen GA; Andersen OM; Bonvin AM; Bjerrum-Bohr I; Etzerodt M; Thøgersen HC; O'Shea C; Poulsen FM; Kragelund BB
    J Mol Biol; 2006 Sep; 362(4):700-16. PubMed ID: 16938309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of 3D atomic similarities and their use in the discrimination of small molecule protein-binding sites.
    Najmanovich R; Kurbatova N; Thornton J
    Bioinformatics; 2008 Aug; 24(16):i105-11. PubMed ID: 18689810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New capabilities in determining the binding parameters for ligand-receptor interaction.
    Bobrovnik S
    J Biochem Biophys Methods; 2005 Oct; 65(1):30-44. PubMed ID: 16188321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1.7 A refined X-ray structure of the periplasmic glucose/galactose receptor from Salmonella typhimurium.
    Zou JY; Flocco MM; Mowbray SL
    J Mol Biol; 1993 Oct; 233(4):739-52. PubMed ID: 8240551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and functional analysis of G protein-coupled receptors and potential diagnostic ligands.
    Fraser CM
    J Nucl Med; 1995 Jun; 36(6 Suppl):17S-21S. PubMed ID: 7769460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
    Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
    Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
    Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
    Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.